2017
DOI: 10.1038/ncomms15150
|View full text |Cite
|
Sign up to set email alerts
|

Antibody-powered nucleic acid release using a DNA-based nanomachine

Abstract: A wide range of molecular devices with nanoscale dimensions have been recently designed to perform a variety of functions in response to specific molecular inputs. Only limited examples, however, utilize antibodies as regulatory inputs. In response to this, here we report the rational design of a modular DNA-based nanomachine that can reversibly load and release a molecular cargo on binding to a specific antibody. We show here that, by using three different antigens (including one relevant to HIV), it is possi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
90
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 116 publications
(90 citation statements)
references
References 43 publications
0
90
0
Order By: Relevance
“…We hypothesized that if one of the protein targets for such synthetic protein binders would be located on the cell surface, their regulatory effect 21 could be extended from the protein level to the cellular level. We also expected that the ability to reversibly change the structure of such DNA-based protein binders [11][12][13][14][15][16][17][18][19][20][21][22] and precisely control the orientation, distance, and valency of their binding units [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] would enable such systems to act as artificial CSPs. Namely, as artificial receptors that respond to dynamic changes in the environment and can endow the bacteria with engineered properties.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…We hypothesized that if one of the protein targets for such synthetic protein binders would be located on the cell surface, their regulatory effect 21 could be extended from the protein level to the cellular level. We also expected that the ability to reversibly change the structure of such DNA-based protein binders [11][12][13][14][15][16][17][18][19][20][21][22] and precisely control the orientation, distance, and valency of their binding units [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] would enable such systems to act as artificial CSPs. Namely, as artificial receptors that respond to dynamic changes in the environment and can endow the bacteria with engineered properties.…”
Section: Resultsmentioning
confidence: 99%
“…The advantages of using ODN-small-molecule conjugates as synthetic protein binders include the ability to precisely control the orientation, distances, and valency of their binding units [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] , as well as the ability to dynamically change their structure, which provides a means to regulate protein functions in real time [11][12][13][14][15][16][17][18][19][20][21] . This work shows that when synthetic protein binders of this class are attached to cell surfaces, their regulatory effect can be extended from the protein level to the cellular level.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Our two‐step assay has built a bridge between the nanopore‐based single molecule method and DNA‐based circuitry designs. Apart from the aptamer‐based conformation changes used in this work, direct binding of antibodies and other proteins can also facilitate successful signal translation into output strands . Compared to the traditional fluorescence assays, our method avoids fluorophores conjugation and spectra overlap.…”
Section: Resultsmentioning
confidence: 99%